Cargando…

Subunit Vaccine Approaches for African Swine Fever Virus

African swine fever virus (ASFV) is the cause of a highly fatal disease in swine, for which there is no available vaccine. The disease is highly contagious and poses a serious threat to the swine industry worldwide. Since its introduction to the Caucasus region in 2007, a highly virulent, genotype I...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudreault, Natasha N., Richt, Juergen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631172/
https://www.ncbi.nlm.nih.gov/pubmed/31242632
http://dx.doi.org/10.3390/vaccines7020056
_version_ 1783435461593661440
author Gaudreault, Natasha N.
Richt, Juergen A.
author_facet Gaudreault, Natasha N.
Richt, Juergen A.
author_sort Gaudreault, Natasha N.
collection PubMed
description African swine fever virus (ASFV) is the cause of a highly fatal disease in swine, for which there is no available vaccine. The disease is highly contagious and poses a serious threat to the swine industry worldwide. Since its introduction to the Caucasus region in 2007, a highly virulent, genotype II strain of ASFV has continued to circulate and spread into Eastern Europe and Russia, and most recently into Western Europe, China, and various countries of Southeast Asia. This review summarizes various ASFV vaccine strategies that have been investigated, with focus on antigen-, DNA-, and virus vector-based vaccines. Known ASFV antigens and the determinants of protection against ASFV versus immunopathological enhancement of infection and disease are also discussed.
format Online
Article
Text
id pubmed-6631172
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66311722019-08-19 Subunit Vaccine Approaches for African Swine Fever Virus Gaudreault, Natasha N. Richt, Juergen A. Vaccines (Basel) Review African swine fever virus (ASFV) is the cause of a highly fatal disease in swine, for which there is no available vaccine. The disease is highly contagious and poses a serious threat to the swine industry worldwide. Since its introduction to the Caucasus region in 2007, a highly virulent, genotype II strain of ASFV has continued to circulate and spread into Eastern Europe and Russia, and most recently into Western Europe, China, and various countries of Southeast Asia. This review summarizes various ASFV vaccine strategies that have been investigated, with focus on antigen-, DNA-, and virus vector-based vaccines. Known ASFV antigens and the determinants of protection against ASFV versus immunopathological enhancement of infection and disease are also discussed. MDPI 2019-06-25 /pmc/articles/PMC6631172/ /pubmed/31242632 http://dx.doi.org/10.3390/vaccines7020056 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gaudreault, Natasha N.
Richt, Juergen A.
Subunit Vaccine Approaches for African Swine Fever Virus
title Subunit Vaccine Approaches for African Swine Fever Virus
title_full Subunit Vaccine Approaches for African Swine Fever Virus
title_fullStr Subunit Vaccine Approaches for African Swine Fever Virus
title_full_unstemmed Subunit Vaccine Approaches for African Swine Fever Virus
title_short Subunit Vaccine Approaches for African Swine Fever Virus
title_sort subunit vaccine approaches for african swine fever virus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631172/
https://www.ncbi.nlm.nih.gov/pubmed/31242632
http://dx.doi.org/10.3390/vaccines7020056
work_keys_str_mv AT gaudreaultnatashan subunitvaccineapproachesforafricanswinefevervirus
AT richtjuergena subunitvaccineapproachesforafricanswinefevervirus